文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

碘化直肠间隔物在前列腺光子与质子放疗中的特性研究

Characterization of an Iodinated Rectal Spacer for Prostate Photon and Proton Radiation Therapy.
PubMed 文献 · Pract Radiat Oncol · 2021-10-05

本研究对比了碘化直肠间隔物(I-SP)与传统间隔物(nonI-SP)在前列腺癌放疗中的放置、稳定性及计划质量。I-SP在计划CT上呈现明显高对比度(HU 138 vs 12,P < .001),可单独用于勾画而无需MRI。I-SP的体积和表面积较小,但相对位置及前列腺-直肠间距相似,且在整个疗程中保持稳定,计划质量与稳健性无显著差异。

要点

  • I-SP在CT上HU值显著高于nonI-SP(138 vs 12,P < .001),可独立勾画。
  • I-SP体积和表面积小于nonI-SP,但位置和间距相似。
  • I-SP在28至44次治疗中HU、体积、位置稳定,计划质量无差异。

核心结论

  • I-SP提供明显的CT对比度,可单独在计划CT上勾画而无需MRI。
  • I-SP的影像学特性、大小和相对位置在整个疗程中保持稳定。
  • I-SP与nonI-SP相比,计划质量和稳健性无显著变化。

研究设计与样本

  • 研究纳入50例接受光子放疗的I-SP患者,与随机选取的50例nonI-SP患者(光子或质子治疗)进行比较。
  • 在计划CT上勾画I-SP,并在首次、中间和末次治疗时于锥形束CT上勾画(共200次扫描)。
  • 比较计划CT上I-SP的HU值、体积、表面积、质心位置及前列腺-直肠质心距离。
  • 通过体模测试I-SP对质子的相对线性停止本领。

主要发现

  • I-SP在计划CT上HU值为138,nonI-SP为12(P < .001)。
  • I-SP勾画体积为8.9 mL,nonI-SP为10.6 mL(P < .001);表面积分别为28 cm2和35 cm2(P < .001)。
  • 相对间隔物位置和前列腺-直肠分离度相似(P = .79)。
  • I-SP水凝胶的HU、体积、表面积或相对位置在整个疗程中无显著变化(所有P > .1)。
  • I-SP相对线性停止本领为1.018,质子计划需进行HU覆盖。

关键数值与推荐

  • I-SP在CT上HU值138 vs nonI-SP 12,P < .001。
  • I-SP体积8.9 mL vs nonI-SP 10.6 mL,P < .001;表面积28 cm2 vs 35 cm2,P < .001。
  • 相对位置和前列腺-直肠分离度相似,P = .79。
  • I-SP特性在整个疗程中无显著变化,所有P > .1。
  • I-SP相对线性停止本领1.018,质子计划需HU覆盖。

临床怎么用

  • I-SP可用于计划CT单独勾画,避免MRI检查。
  • I-SP在光子放疗中计划质量与nonI-SP相当。
  • 质子放疗中使用I-SP需进行HU覆盖以校正停止本领。

局限性

  • 研究为回顾性比较,样本量有限(每组50例)。
  • 未报告长期临床结局或毒性数据。
  • 体模测试结果需临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Conventional rectal spacers (nonI-SPs) are low-contrast on computed tomography (CT), often necessitating magnetic resonance imaging for accurate delineation. A new formulation of spacers (I-SPs) incorporates iodine to improve radiopacity and CT visualization. We characterized placement, stability, and plan quality of I-SPs compared to nonI-SPs. METHODS AND MATERIALS: Patients with intact prostate cancer (n = 50) treated with I-SPs and photons were compared to randomly selected patients (n = 50) with nonI-SPs (photon or proton therapy). The I-SP was contoured on the planning CT and cone beam CTs at 3 timepoints: first, middle, and final treatment (n = 200 scans). I-SPs Hounsfield units (HU), volume, surface area (SA), centroid position relative to prostate centroid, and distance between prostate/rectum centroids were compared on the planning CTs between each cohort. I-SP changes were evaluated on cone beam CTs over courses of treatment. Dosimetric evaluations of plan quality and robustness were performed. I-SP was tested in a phantom to characterize its relative linear stopping power for protons. RESULTS: I-SPs yielded a distinct visible contrast on planning CTs compared to nonI-SPs (HU 138 vs 12, P < .001), allowing delineation on CT alone. The delineated volume and SA of I-SPs were smaller than nonI-SPs (volume 8.9 vs 10.6 mL, P < .001; SA 28 vs 35 cm2, P < .001), yet relative spacer position and prostate-rectal separation were similar (P = .79). No significant change in HU, volume, SA, or relative position of the I-SPs hydrogel occurred over courses of treatment (all P > .1). Dosimetric analysis concluded there were no significant changes in plan quality or robustness for I-SPs compared to nonI-SPs. The I-SP relative linear stopping power was 1.018, necessitating HU override for proton planning. CONCLUSIONS: I-SPs provide a manifest CT contrast, allowing for delineation on planning CT alone with no magnetic resonance imaging necessary. I-SPs radiopacity, size, and relative position remained stable over courses of treatment from 28 to 44 fractions. No changes in plan quality or robustness were seen comparing I-SPs and nonI-SPs.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kamran SC, McClatchy DM, Pursley J, et al. Characterization of an Iodinated Rectal Spacer for Prostate Photon and Proton Radiation Therapy. Pract Radiat Oncol. 2021. PMID: 34619374. doi:10.1016/j.prro.2021.09.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。